BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 31489788)

  • 1. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
    Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
    Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
    J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
    Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
    Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
    J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
    Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
    Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of radiculopathy caused by second course of spine stereotactic body radiotherapy.
    Ito K; Nakajima Y; Ogawa H; Taguchi K; Sugita S
    Jpn J Clin Oncol; 2022 Aug; 52(8):911-916. PubMed ID: 35462409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
    Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
    J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.
    Ito K; Nihei K; Shimizuguchi T; Ogawa H; Furuya T; Sugita S; Hozumi T; ; Karasawa K
    J Neurosurg Spine; 2018 Sep; 29(3):332-338. PubMed ID: 29905524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
    Silva SR; Gliniewicz A; Martin B; Prabhu VC; Germanwala AV; Melian E; Jones GA; Solanki AA
    World Neurosurg; 2019 Feb; 122():e342-e348. PubMed ID: 30326310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
    Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M
    Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiotherapy for Spinal Metastases: Clinical Experience in 134 Cases From a Single Japanese Institution.
    Ito K; Ogawa H; Shimizuguchi T; Nihei K; Furuya T; Tanaka H; Karasawa K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806472. PubMed ID: 30355246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases.
    Boehling NS; Grosshans DR; Allen PK; McAleer MF; Burton AW; Azeem S; Rhines LD; Chang EL
    J Neurosurg Spine; 2012 Apr; 16(4):379-86. PubMed ID: 22225488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
    Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
    J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
    Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.
    Cunha MV; Al-Omair A; Atenafu EG; Masucci GL; Letourneau D; Korol R; Yu E; Howard P; Lochray F; da Costa LB; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e343-9. PubMed ID: 22658511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
    Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiotherapy for Spinal Metastases: What are the Risks and How Do We Minimize Them?
    Chang JH; Shin JH; Yamada YJ; Mesfin A; Fehlings MG; Rhines LD; Sahgal A
    Spine (Phila Pa 1976); 2016 Oct; 41 Suppl 20(Suppl 20):S238-S245. PubMed ID: 27488294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.